tiprankstipranks
Trending News
More News >
AbCellera Biologics (ABCL)
NASDAQ:ABCL

AbCellera Biologics (ABCL) Revenue

Compare
2,217 Followers

AbCellera Biologics Revenue

AbCellera Biologics had a revenue of 8.96M in the quarter ending Sep 30, 2025, with -47.58%. This bring the company's revenue in the last twelve months to 35.32M, Decreased 7.45%. In the fiscal year ending Dec 31, 2024, AbCellera Biologics had annual revenue of 28.83M with -24.17% growth.
Revenue (ttm)
35.32M
Revenue Growth
7.16%
P/S Ratio
39.14
Revenue/Employee
$48,378
Employees
596
Market Cap
$1.13B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
28.83M-9.19M+75.83%
Dec 31, 2023
38.02M-447.40M+7.83%
Dec 31, 2022
485.42M110.22M+129.38%
Dec 31, 2021
375.20M142.05M+160.92%
Dec 31, 2020
233.16M221.54M+2,007.88%
Dec 31, 2019
11.61M2.78M+131.49%
Dec 31, 2018
8.83M